Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: CLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1b) [Phase 3]
Phase 3 trial evaluating rituximab with chlorambucil versus chlorambucil alone in previously untreated chronic lymphocytic leukemia; results…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
This Phase 2 clinical trial update evaluates lenalidomide in previously treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma.…
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia [NA]
This clinical trial update reports compassionate-use treatment with Campath-1H (alemtuzumab) for patients with refractory prolymphocytic leu…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 3]
Phase 3 trial comparing fludarabine and cyclophosphamide with or without oblimersen in relapsed or refractory chronic lymphocytic leukemia h…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia [Phase 3]
Phase 3 clinical trial update evaluating chemotherapy for newly diagnosed chronic lymphocytic leukemia. The study status indicates completio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) [Phase 2]
A Phase 2 trial evaluated the combination of ofatumumab and bendamustine in frontline and relapsed chronic lymphocytic leukemia; the study r…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia [Phase 4]
The Phase 4 study evaluating fludarabine phosphate in untreated chronic lymphocytic leukemia patients with anemia and/or thrombocytopenia ha…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)
Observational study assessing quality of life in patients with chronic B-cell lymphocytic leukemia (B-CLL) who are under treatment; the Vita…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia
This clinical trial update reports on the safety, effectiveness, and patient acceptance of MabCampath (alemtuzumab) in chronic lymphocytic l…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match [Phase 2]
Phase 2 trial evaluating pooled unrelated donor umbilical cord blood transplant for hematologic malignancies requiring allogeneic stem cell …
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) [Phase 2]
A Phase 2 trial investigating prevention of disease progression in early-stage indolent B-cell malignancies (MGUS, smoldering multiple myelo…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine [Phase 2]
Phase 2 trial update for alemtuzumab in advanced chronic lymphocytic leukemia that did not respond to prior fludarabine reports the study st…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia [Phase 2]
An NCI-sponsored Phase 2 trial evaluated thalidomide in relapsed/refractory chronic lymphocytic leukemia and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 trial evaluating the activity and safety of a non-chemotherapy-based combination of lenalidomide and rituximab in chronic lymphocy…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating decitabine in combination with valproic acid for adults with refractory or relapsed acute myeloid leukemia or previ…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial evaluating bortezomib and fludarabine with or without rituximab in relapsed or refractory indolent non-Hodgkin lymphoma or chr…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial of SJG-136 in relapsed or refractory hematologic cancers (acute myeloid leukemia subtypes, myelodysplastic syndromes, blast-ph…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial update of obatoclax, fludarabine, and rituximab in previously treated chronic lymphocytic leukemia; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial evaluating IDEC-152 for chronic lymphocytic leukemia reported safety and preliminary efficacy results.
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older [Phase 2]
Phase 2 clinical trial update evaluating lenalidomide as initial treatment in older patients with chronic lymphocytic leukemia; results post…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated escalating doses of lenalidomide in combination with rituximab and fludarabine in untreated chronic lym…
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 trial evaluating bendamustine hydrochloride injection as initial therapy for chronic lymphocytic leukemia has been completed.
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial of bendamustine plus alemtuzumab in refractory chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated. The…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) [Phase 2]
Phase 2 clinical trial evaluating dasatinib (BMS-354825) for chronic lymphocytic leukemia has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission [Phase 2]
Phase 2 clinical trial evaluating alemtuzumab in patients with B-cell chronic lymphocytic leukemia who are in partial or complete remission.…